telehealth semaglutide provider us Him & Hers now offers all FDA-approved GLP-1s Fridays | GLP-1 Telehealth |

Commenting on the results, Amira Guirguis, chief scientist at the Royal Pharmaceutical Society, said: Retatrutide shows the potential for exceptional weight-loss outcomes that, if maintained, could meaningfully improve mobility, obesity-related morbidity and overall quality of life

The researchers did not analyze whether patients had a prior history of gout, which could also influence risk

However, in the context of a drug that also dramatically improves metabolic healthreducing weight, improving insulin sensitivity, and lowering blood pressurethe net effect could be overwhelmingly positive

doi: 10.1111/j.1742-1241.2012.02911.x 13 ItoDInoueKSaitoDHamaguchiKKanekoKSumitaTet al

If youre on antidepressants or medications for blood pressure, migraines or insulin resistance, drug interactions should also be reviewed